Trial Profile
Phase 1 study of TS-1 with Abraxane for metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 01 Dec 2016 Results published in the Anticancer Research
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 29 Jul 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan